Zweig-DiMenna Associates’s Verona Pharma VRNA Stock Holding History

Zweig-DiMenna Associates’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-72,518	Closed	-$7.74M	–	120
2025 Q3	$7.74M	Sell	72,518 -1,732	-2%	-$181K	0.54%	63
2025 Q2	$7.02M	Buy	+74,250	New	+$5.5M	0.66%	49

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Zweig-DiMenna Associates's VRNA Position: Q4 2025 in Review

Zweig-DiMenna Associates sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 72,518 shares — an estimated $7.74M sold.

Zweig-DiMenna Associates first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $7.74M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Zweig-DiMenna Associates reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Zweig-DiMenna Associates sold 72,518 Verona Pharma shares in Q4 2025, an estimated $7.74M.
Zweig-DiMenna Associates first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Zweig-DiMenna Associates's Verona Pharma position peaked at $7.74M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Zweig-DiMenna Associates's 13F filing for Q4 2025, filed 10 Feb 2026.